In this episode of The Psychedelic Podcast, Paul F. Austin welcomes Bryan Hubbard, a prominent advocate for psychedelic-assisted therapies, particularly ibogaine in the treatment of opioid addiction and mental health disorders.

Find full show notes and links here: https://thethirdwave.co/podcast/episode-305/?ref=278

Update (May 2025): Days before this episode's release, the Texas House approved a Senate-backed bill to fund ibogaine research through a public-private partnership aimed at securing FDA approval. This vote marks a major milestone in the movement Bryan describes throughout this conversation.

Bryan shares his journey from leading Kentucky's Opioid Abatement Advisory Commission to spearheading breakthrough ibogaine research initiatives in Texas. He articulates ibogaine's unique neurological properties, discussing how it can reset brain neurochemistry in 36 hours and potentially treat conditions from traumatic brain injury to Parkinson's disease. The conversation explores the spiritual dimensions of ibogaine experiences, the political landscape surrounding psychedelic medicine, and Bryan's ongoing efforts to medicalize ibogaine through FDA drug development trials, highlighting Texas as the next frontier for this life-saving research.

W. Bryan Hubbard is the Executive Director of the American Ibogaine Initiative. He is the first and former Chairman and Executive Director of the Kentucky Opioid Abatement Advisory Commission. He concurrently served as Special Counsel to the Kentucky Attorney General’s Office of Medicaid Fraud and Abuse Control and was its prior Executive Director. He served on the Kentucky Judicial Commission on Mental Health, the Kentucky Child Support Guidelines Commission, Mine Safety Review Board, and the Kentucky Office of Drug Control Policy’s Recovery Ready Communities Advisory Council. He previously served as Commissioner of the Kentucky Department of Income Support wherein he led the Commonwealth’s Social Security Disability and Child Support Enforcement systems. He practiced workers’ compensation law representing Walmart, Tyson Foods, and Tennessee Valley Authority for sixteen years. During his practice years, he observed the predacious onset of Kentucky’s Opioid Epidemic amid generational joblessness, poverty, disability, and substance use. He was raised in Virginia’s coalfields and is the proud grandson of two grade-school educated coal miners on whose shoulders he stands.

Highlights:

Why ibogaine interrupts addiction instantly
The Stanford study that changed everything
Resetting brain neurochemistry in 36 hours
From Parkinson's to PTSD: Ibogaine's broad applications
The spiritual awakening dimension of treatment
How pharmaceutical interests block breakthrough medicine
Kentucky's lost opportunity: $42 million for research
Texas as the new frontier for ibogaine medicalization
Matrix pharmacology: Ibogaine's intelligent mechanism
The political war over life-saving psychedelic medicine

Episode Links

Episode Sponsors:

Golden Rule Mushrooms - Get a lifetime discount of 10% with code THIRDWAVE at checkout

Show 1335: Visual Thinking and the Value of Neurodiversity